首页> 外文期刊>Oxidative Medicine and Cellular Longevity >The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases
【24h】

The Role of Posttranslational Modification and Mitochondrial Quality Control in Cardiovascular Diseases

机译:后期改性和线粒体质量控制在心血管疾病中的作用

获取原文
       

摘要

Cardiovascular disease (CVD) is the leading cause of death in the world. The mechanism behind CVDs has been studied for decades; however, the pathogenesis is still controversial. Mitochondrial homeostasis plays an essential role in maintaining the normal function of the cardiovascular system. The alterations of any protein function in mitochondria may induce abnormal mitochondrial quality control and unexpected mitochondrial dysfunction, leading to CVDs. Posttranslational modifications (PTMs) affect protein function by reversibly changing their conformation. This review summarizes how common and novel PTMs influence the development of CVDs by regulating mitochondrial quality control. It provides not only ideas for future research on the mechanism of some types of CVDs but also ideas for CVD treatments with therapeutic potential.
机译:心血管疾病(CVD)是世界上死亡的主要原因。 几十年来研究了CVDS背后的机制; 然而,发病机制仍然存在争议。 线粒体稳态在维持心血管系统的正常功能方面发挥着重要作用。 线粒体中任何蛋白质功能的改变可能诱导导致CVDS的异常线粒体质量控制和意外的线粒体功能障碍。 后期修饰(PTMS)通过可逆地改变其构象来影响蛋白质功能。 本综述总结了通过调节线粒体质量控制的常见和新的PTMS影响CVDS的发育。 它不仅提供了未来研究某些类型的CVD机制的研究,而且提供了对具有治疗潜力的CVD治疗的想法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号